Literature DB >> 25602702

Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

Kazim Sahin1, Brian Cross2, Nurhan Sahin1, Karina Ciccone2, Shadeah Suleiman2, Adeboye O Osunkoya2, Viraj Master2, Wayne Harris2, Bradley Carthon2, Ramzi Mohammad3, Birdal Bilir2, Karin Wertz4, Carlos S Moreno2, Cheryl L Walker5, Omer Kucuk6.   

Abstract

Renal cell carcinoma (RCC) is the most frequent upper urinary tract cancer in humans and accounts for 80-85% of malignant renal tumors. Eker rat represents a unique animal model to study RCC since these rats develop spontaneous renal tumors and leiomyoma, which may be due to tuberous sclerosis 2 (TSC2) mutation resulting in the activation of the mammalian target of rapamycin (mTOR) pathway. This study examines the role of a lycopene-rich diet in the development of RCC in the TSC2 mutant Eker rat model. Ten-week old female Eker rats (n=90) were assigned in equal numbers to receive 0, 100 or 200mg/kg of lycopene as part of their daily diet. After 18 months the rats were sacrificed and the kidneys were removed. Immunohistochemical staining with antibodies against mTOR, phospho-S6 and EGFR were performed, as well as hematoxylin-eosin staining for histologic examination of the tumors. Tumors were counted and measured in individual kidneys. Presence of tumor decreased from 94% in control animals to 65% in the experimental group, but the difference was not statistically significant (P<0.12). However, mean numbers of renal carcinomas were statistically significantly decreased in the lycopene-treated rats (P<0.008) when compared to untreated controls. In the lycopene group, tumor numbers decreased (P<0.002) and the numbers tended to decrease linearly (P<0.003) as supplemental lycopene increased from 0 to 200. Control rats fed only basal diet had a greater length of tumors (23.98 mm) than rats fed lycopene supplement groups (12.90 mm and 11.07 mm) (P<0.05). Moreover tumor length decreased (P<0.02) and tumor length tended to decrease linearly (P<0.03) as supplemental lycopene increased from 0 to 200mg/kg. All tumors showed strong staining with antibodies against mTOR, phospho-S6 and EGFR. In conclusion, dietary supplementation with lycopene attenuates the development of renal cell cancers in the predisposed TSC2 mutant Eker rat model. These results suggest that lycopene may play a role in the prevention of RCC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eker rat; Lycopene; Renal cell cancer

Mesh:

Substances:

Year:  2015        PMID: 25602702      PMCID: PMC5657428          DOI: 10.1016/j.abb.2015.01.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  31 in total

Review 1.  Insulin-like growth factor-I and binding protein-3 and risk of cancer.

Authors:  E Giovannucci
Journal:  Horm Res       Date:  1999

2.  Consumption of different types of meat and the risk of renal cancer: meta-analysis of case-control studies.

Authors:  Mohammed F Faramawi; Eric Johnson; M Whitney Fry; Macodu Sall; Yi Zhou; Zhou Yi
Journal:  Cancer Causes Control       Date:  2007-01-22       Impact factor: 2.506

3.  Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model.

Authors:  Feng-Yao Tang; Man-Hui Pai; Xiang-Dong Wang
Journal:  J Agric Food Chem       Date:  2011-07-25       Impact factor: 5.279

4.  Epidemiology of renal-cell carcinoma.

Authors:  A Tavani; C La Vecchia
Journal:  J Nephrol       Date:  1997 Mar-Apr       Impact factor: 3.902

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage?

Authors:  P Riso; A Pinder; A Santangelo; M Porrini
Journal:  Am J Clin Nutr       Date:  1999-04       Impact factor: 7.045

Review 7.  A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer.

Authors:  Edward Giovannucci
Journal:  Exp Biol Med (Maywood)       Date:  2002-11

8.  Lycopene as the most efficient biological carotenoid singlet oxygen quencher.

Authors:  P Di Mascio; S Kaiser; H Sies
Journal:  Arch Biochem Biophys       Date:  1989-11-01       Impact factor: 4.013

9.  Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer.

Authors:  Jung Eun Lee; Edward Giovannucci; Stephanie A Smith-Warner; Donna Spiegelman; Walter C Willett; Gary C Curhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-12       Impact factor: 4.254

10.  Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action.

Authors:  L X Zhang; R V Cooney; J S Bertram
Journal:  Carcinogenesis       Date:  1991-11       Impact factor: 4.944

View more
  5 in total

Review 1.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

Review 2.  Can Diet Prevent Urological Cancers? An Update on Carotenoids as Chemopreventive Agents.

Authors:  Tomasz Konecki; Aleksandra Juszczak; Marcin Cichocki
Journal:  Nutrients       Date:  2022-03-25       Impact factor: 5.717

3.  Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma.

Authors:  Gianni Paulis; Enzo Berardesca
Journal:  Res Rep Urol       Date:  2019-08-20

4.  Inclusion Complexes of Lycopene and β-Cyclodextrin: Preparation, Characterization, Stability and Antioxidant Activity.

Authors:  Haixiang Wang; Shaofeng Wang; Hua Zhu; Suilou Wang; Jiudong Xing
Journal:  Antioxidants (Basel)       Date:  2019-08-16

Review 5.  Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers.

Authors:  Die Qian; Lisha He; Qing Zhang; Wenqing Li; Dandan Tang; Chunjie Wu; Fei Yang; Ke Li; Hong Zhang
Journal:  Curr Oncol       Date:  2022-08-22       Impact factor: 3.109

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.